F073 CrossTalk: Interdisciplinary Dermatology Made Simple
DESCRIPTION
This innovative focus session will provide key insights into the clinical diagnosis and management of systemic manifestations of inflammatory skin diseases. We will explore collaborative, interdisciplinary strategies to co-manage a range of cutaneous diseases across medical disciplines, including Rheumatology, Pulmonology, Allergy and Immunology, Gastroenterology, and Endocrinology. These talks will highlight shared pathophysiologic mechanisms and integrated treatments that address multiple comorbidities to enhance and optimize clinical outcomes and the patient experience.
LEARNING OBJECTIVES
Analyze and identify overlapping immunopathologic mechanisms across both dermatology and other medical disciplines (GI, Pulm, Allergy, Rheum, and Endo) to inform interdisciplinary management
Diagnose complex multisystem conditions by identifying key clinical and laboratory findings that require multispecialty evaluation and collaboration
Evaluate therapies that provide therapeutic benefit across multiple organ systems, and develop management plans to optimize both dermatologic and systemic outcomes
SCHEDULE
9:00 AM
CrossTalk: Interdisciplinary Dermatology Made Simple
DIRECTOR
Ahuva Danielle Cices, MD, FAAD
SPEAKERS
Saakshi Khattri, MD, MBBS, FAAD
Jordan Talia, MD, FAAD
DISCLOSURES
Ahuva Danielle Cices, MD, FAAD
No financial relationships exist with ineligible companies.
Saakshi Khattri, MD, MBBS, FAAD
AbbVie – Speaker(Honoraria); BMS – Investigator(Grants/Research Funding); Eli Lilly and Company – Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Speaker(Honoraria); Novartis – Advisory Board(Honoraria), Consultant(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding), Speaker(Fees); Sanofi/Regeneron – Advisory Board(Honoraria); ucb – Advisory Board(Honoraria); UCB – Speaker(Honoraria);
Jordan Talia, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); Attovia Therapeutics – Investigator(Fees); Bristol Myers Squibb – Consultant (1099 relationship)(Honoraria); Edesa Biotech – Stockholder Public Company(Stock); Equillium, Inc. – Stockholder Public Company(Stock); Galderma – Consultant (1099 relationship)(Honoraria); HCW Biologics – Stockholder Public Company(Stock); Incyte – Consultant (1099 relationship)(Honoraria); Johnson and Johnson – Consultant (1099 relationship)(Honoraria); Kymera Therapeutics – Other(Stock Options); Leo Pharma – Consultant (1099 relationship)(Honoraria), Investigator(Fees); Navigator Medicines – Consultant (1099 relationship)(Honoraria); Nektar Therapeutics – Stockholder Public Company(Stock); Novartis – Consultant (1099 relationship)(Honoraria); Primus Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Investigator(Fees); Q32 Bio Inc. – Other(Stock); Sanofi – Consultant (1099 relationship)(Honoraria), Investigator(Fees); Scinai Immunotherapeutics – Stockholder Public Company(Stock); Stifel Financial – Consultant (1099 relationship)(Honoraria); UCB – Consultant (1099 relationship)(Honoraria); Zura Bio – Stockholder Public Company(Stock);